Show Notes
Gene and stem cell therapies have been touted as the next phase in the longevity movement, with promises to rejuvenate the body at the cellular level and reverse the effects of ageing. But, as the prospect of life extension moves into the mainstream, it presents big questions for society as a whole. Are we ready for a world where people live much longer lives?
In this final episode, the FT’s Michael Peel and Hannah Kuchler dive into the tough moral questions at the heart of the longevity movement. Hannah speaks to the team at Fountain Life, a longevity clinic trying to bring stem cell therapy to the middle classes. We meet Daniel Ives, founder of gene therapy company Shift Bioscience, and Liz Parrish, who has self-experimented with gene therapies through her company, Biovia. Finally, Michael speaks to Arthur Caplan, the head of the ethics board of longevity fund, Hevolution.
Free to read: From immortal jellyfish to elephants: scientists probe secrets of long-lived animals Inside the billion-dollar quest to live beyond 100 Gene editing breakthrough promises to boost fight against disease
This series of Tech Tonic is hosted by Michael Peel and Hannah Kuchler. It is produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Special thanks to Michela Tindera.
Clips: Al Jazeera Balkans, TV France Japon, ABP News, Rome Reports, @Sciencerely
The FT does not use generative AI to voice its podcasts.
Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
More from FT Tech Tonic
Could AI help us understand ourselves and each other better? Writer and philosopher Alain de Botton speaks to the FT’s Madhumita Murgia about the challenges we face navigating human relationships, and how AI might be able to help. Recorded live at the FT Weekend Festival.
Murad Ahmed speaks to FT journalist Sarah O’Connor about her new book ‘We Are Not Machines’, which explores the impact AI is already having on workplaces. They discuss how Swedish miners dealt with the introduction of AI-powered vehicles, and how Czech translators found AI stealing the most creative part of their job. Recorded live at the FT Weekend Festival.
AI-related investments are now worth up to half of the entire value of the S&P 500. But is the AI investment boom a bubble waiting to burst? Tim Bradshaw, the FT’s global technology correspondent, speaks to Richard Kramer, founder of Arete Research, and Ophelia Brown, founder of Blossom Capital. Recorded live at the FT Weekend Festival on 5th September 2026.
At the Enhanced Games in Las Vegas earlier this year, athletes used performance-enhancing drugs and banned equipment in an attempt to break world records. At the same time, companies such as Adidas are designing new types of equipment that fall within the rules, but give athletes an edge. So where is the line between cheating and innovation?
Video-assistant refereeing (VAR) has proved to be one of the most controversial pieces of technology ever introduced in sports. But with the rise of everything from broadcasting gimmicks to data-driven gambling, it’s far from the only technology changing what it means to be a fan. The FT’s sports editor Josh Noble asks whether these advancements are making sport more fun to watch, or overshadowing the event itself.